LIVE: FDA Workshop Focuses on Pediatric Hypertension Treatments (DAY 2)

Live News Network
1.4K followers
Jul 16, 2026
The U.S. Food and Drug Administration continues its public workshop at 9 a.m. ET on July 16 on the development of antihypertensive therapies for pediatric patients. The second day focuses on advancing treatment strategies and generating evidence for the safe and effective use of blood pressure medications in children, including those under 6 years old.
AI Generated·May contain errors
Video Summary
AI GeneratedThis workshop addresses the regulatory and clinical challenges of developing antihypertensive treatments for pediatric patients with uncontrolled hypertension. Experts discuss the need for pediatric-specific diagnostic criteria, the impact of comorbidities like obesity and sleep apnea, and the balance between rigorous clinical trial design and the urgent need for effective therapies.
